Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
about
Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureNitric oxide synthases in heart failureNADPH oxidases in heart failure: poachers or gamekeepers?Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesNebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.Cardiac NO signalling in the metabolic syndrome.Pulmonary Macrophages Attenuate Hypoxic Pulmonary Vasoconstriction via β3AR/iNOS Pathway in Rats Exposed to Chronic Intermittent Hypoxia.Nebivolol: impact on cardiac and endothelial function and clinical utility.Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockadeRegulation of Overnutrition-Induced Cardiac Inflammatory MechanismsRegulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.Risk-based classification of hypertension and the role of combination therapy.Nitric oxide mechanisms of nebivolol.Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis.The potential of stimulating nitric oxide formation in the treatment of hypertension.Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure.Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
P2860
Q26822825-EED0AC3F-5BB6-47C2-A2B1-42F0020E3F6BQ26830146-B56A64B0-E9CB-441B-99A3-A4D6AF747EE0Q27001094-5F2BF354-FEC0-45AF-BE11-32371AE27B79Q28073279-18BA75D1-98AF-4E91-B3E9-01BEB901F76FQ33645780-3F4D614F-B960-422A-AFFC-6E4D3C235696Q33838174-0D4777A6-59B8-4B80-8AA0-BD57D9B4D767Q35204828-58AB1579-8785-4C4F-806A-A676EE52C1DEQ35680117-2DF0CDDB-E72B-4EB6-82EA-81A0C7A77A2FQ35846698-1FB4D630-F0F5-4C2C-848B-A7664D88C0C0Q36141224-FCF689EA-A454-4B6B-9A2A-61AC849F8142Q36206138-A6189647-5093-4524-B0AC-631D3976236CQ36249066-D493CC1D-AC26-4F6E-B4AC-94FB9CB452F0Q36652837-7A269B84-6D62-4F9A-A376-C1DE1DDF7587Q37050143-0865D2E2-DF9A-46D6-935E-975777E7944BQ37483065-E8E6823E-DF1C-4520-9624-D3C95B6EEAF3Q37600622-4B2A48FF-D3EF-4CF8-8062-93B8922D965EQ37696908-A87C4EB7-6B91-4D99-BAC4-299EFE2F0312Q39198264-E579D84D-4CE3-474F-A12D-4889FB81716AQ41642167-0332EF56-31AB-459A-A1F3-36A48ECFBE29Q44375078-1A940822-A1CD-46CD-96F1-710F44617AADQ58588421-A4CA4F98-07FC-403A-BC5F-4B68986B52D6
P2860
Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@en
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@nl
type
label
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@en
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@nl
prefLabel
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@en
Nebivolol induces nitric oxide ...... ric oxide synthase activation.
@nl
P50
P1433
P1476
Nebivolol induces nitric oxide ...... tric oxide synthase activation
@en
P2093
Roberta Poulet
Rosa Carangi
P304
P356
10.1161/HYPERTENSIONAHA.107.094458
P407
P577
2007-07-30T00:00:00Z